MedPath

Study on the importance of cellular immune response in malignant tumors, autoimmune diseases, immunodeficiency syndromes, after organ transplantation and during pregnancy

Recruiting
Conditions
Cancer, Autoimmune Diseases, Immune Deficiency Syndromes, Pregnancy
Registration Number
DRKS00008016
Lead Sponsor
niversitätsklinikum Köln
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
1000
Inclusion Criteria

Patients: malignant tumor, autoimmune disease, immunodeficiency syndrome, state after organ transplantation, pregnancy.
Control group: healthy volunteers
All of them: written consent

Exclusion Criteria

No written informed consent.
Contraindication for additional blood sampling.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cross-sectional and correlation analysis using flow cytometry and immunohistology of circulating and tissue-resident immune cells in patients and healthy control subjects.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath